|Videos|March 23, 2018

Utilizing Pharmacists in a Team-Based Diabetes Care Model

In this clip, Traci Fritschle, PharmD, explains why pharmacists are uniquely positioned to be utilized in a team-based model for diabetes care.

In this clip, Traci Fritschle, PharmD, explains why pharmacists are uniquely positioned to be utilized in a team-based model for diabetes care. Pharmacists can impact patient care by incorporating face-to-face interactions to review patient reports, discuss trends seen in the report, and explain the impact of the patient's choices with medication adherence and lifestyle behavior.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

Webinar Registration

Stop and Smell the ROSis: Translating Molecular Results Into Actionable Pharmacy Practice in ROS1-Rearranged Non-Small Cell Lung Cancer

January 22, 2026 | 12:00 PM & 7:00 PM ET

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs (Pharmacy Technician Credit)

2.0 Credits / General Pharmacy

Utilizing Pharmacists in a Team-Based Diabetes Care Model

Newsletter

Related Content

Toothpaste Tablets Are Gaining Popularity—Here’s Where Pharmacists Fit In

New Research Highlights Molecular Mechanisms of Gestational Diabetes

Former FDA Chief Scientist Jesse Goodman Breaks Down the Implications of Pediatric Vaccine Guideline Changes

Federal Cervical Cancer Testing Guidelines Expanded to Allow Self-Administered HPV Test

Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy

Latest CME

Stop and Smell the ROSis: Translating Molecular Results Into Actionable Pharmacy Practice in ROS1-Rearranged Non-Small Cell Lung Cancer

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Aiming for Accuracy in Non-Small Cell Lung Cancer Treatment: Precision Strategies for Oncology Pharmacists

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Advancements With CGM Integrations: Insulin Pumps, Connected Pens, and Ketone Monitoring

Improving the Care of Persons Living With Diabetes Using CGM Devices (Pharmacy Technician Credit)

Mastering Hyperlipidemia Management: Enhancing Adherence and Expanding Nonstatin Therapy Options

Balancing Pain Management and Opioid Use Disorder: Recognition, Treatment, and Compassionate Communication in Pharmacy Practice

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Oncology Pharmacists Connect 2026

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Iron Deficiency Anemia Treatment Considerations in Women’s Health

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Exploring ATTR Phenotypes and Identifying Appropriate Opportunities for Pharmacists to Intervene

Advances in Castration-Sensitive Prostate Cancer: A Pharmacist's Approach to Optimize Novel Antiandrogen Therapies

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

The Educated Pharmacist: Overcoming Clinical Inertia—An Interactive Case Workshop for Optimizing Insulin Use

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

Continuing the Conversation: Pharmacist Interventions to Optimize T2D Care and Break Through Clinical Inertia

New and Approved: FDA’s 2024 Drug Lineup

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

New Therapeutic Targets in the Treatment of Generalized Myasthenia Gravis: Understanding Disease Pathways and Pharmacist-Led Strategies for Optimized Care

Managing Steroid-Refractory Chronic Graft-versus-Host Disease With Novel Therapies: Opportunities for Pharmacist-Led Interventions

Collaborative Practice Agreement Implementation and Adherence: A Practical Roadmap for Oncology Pharmacists

Expanding Access to Antibody-Based Regimens in Relapsed/Refractory Multiple Myeloma

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights (Pharmacy Technician Credit)

Advancements With CGM Integrations: Insulin Pumps, Connected Pens, and Ketone Monitoring (Pharmacy Technician Credit)

Improving the Care of Persons Living With Diabetes Using CGM Devices

The Role of IV Iron in Resolving Iron Deficiency in Heart Failure

From Guidelines to Practice: The Pharmacist’s Role in Chronic Heart Failure Therapy Optimization

Empowering Pharmacists in Travel Medicine: Enhancing Patient Care Through Vaccination, Prevention, and Education

Navigating the Complexity of Migraine: A Multimodal Approach to Acute Treatment

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer

Personalizing Treatment in Relapsed/Refractory Multiple Myeloma: The Evolving Role of Antibody-Drug Conjugates and Bispecific Antibodies

Optimizing Therapy in HR+/HER2-Negative Metastatic Breast Cancer: Navigating Novel Treatments and Personalized Care

Expert Insights on the Horizon of HER2-Directed Therapy

Payment for Pharmacist Services: 2025 Update

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies